The Cancer Letter

Inside information on cancer research and drug development

Vol.
30
No.
10
October 26, 2007Oct 26, 2007
Free
DOWNLOAD THE PDF

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

Flavopiridol Plus Cisplatin Tested In Phase II Trial

Trial Combines Drugs Against Blood Vessel Formation

Bevacizumab And Irinotecan May Increase Survival Of GBM

NCI Cooperative Group, Cancer Center Trials Listed

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account